These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 17611640)
1. Fibroblasts mediate induction of high mobility group box protein 1 in lung epithelial cancer cells by diffusible factors. Bartling B; Fuchs C; Silber RE; Simm A Int J Mol Med; 2007 Aug; 20(2):217-24. PubMed ID: 17611640 [TBL] [Abstract][Full Text] [Related]
2. Lung level of HMBG1 is elevated in response to advanced glycation end product-enriched food in vivo. Bartling B; Fuchs C; Somoza V; Niemann B; Silber RE; Simm A Mol Nutr Food Res; 2007 Apr; 51(4):479-87. PubMed ID: 17357979 [TBL] [Abstract][Full Text] [Related]
4. HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells. Rossini A; Zacheo A; Mocini D; Totta P; Facchiano A; Castoldi R; Sordini P; Pompilio G; Abeni D; Capogrossi MC; Germani A J Mol Cell Cardiol; 2008 Apr; 44(4):683-93. PubMed ID: 18328501 [TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells. Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109 [TBL] [Abstract][Full Text] [Related]
6. Human gingival fibroblasts release high-mobility group box-1 protein through active and passive pathways. Feghali K; Iwasaki K; Tanaka K; Komaki M; Machigashira M; Ishikawa I; Izumi Y Oral Microbiol Immunol; 2009 Aug; 24(4):292-8. PubMed ID: 19572890 [TBL] [Abstract][Full Text] [Related]
7. High mobility group box 1 protein is released by neural cells upon different stresses and worsens ischemic neurodegeneration in vitro and in vivo. Faraco G; Fossati S; Bianchi ME; Patrone M; Pedrazzi M; Sparatore B; Moroni F; Chiarugi A J Neurochem; 2007 Oct; 103(2):590-603. PubMed ID: 17666052 [TBL] [Abstract][Full Text] [Related]
8. Proliferative stimulus of lung fibroblasts on lung cancer cells is impaired by the receptor for advanced glycation end-products. Bartling B; Demling N; Silber RE; Simm A Am J Respir Cell Mol Biol; 2006 Jan; 34(1):83-91. PubMed ID: 16166741 [TBL] [Abstract][Full Text] [Related]
9. Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Grover A; Taylor J; Troudt J; Keyser A; Sommersted K; Schenkel A; Izzo AA Cell Microbiol; 2008 Jun; 10(6):1390-404. PubMed ID: 18331466 [TBL] [Abstract][Full Text] [Related]
10. High-mobility group box-1 in ischemia-reperfusion injury of the heart. Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060 [TBL] [Abstract][Full Text] [Related]
11. Growth suppression and radiosensitivity increase by HMGB1 in breast cancer. Jiao Y; Wang HC; Fan SJ Acta Pharmacol Sin; 2007 Dec; 28(12):1957-67. PubMed ID: 18031610 [TBL] [Abstract][Full Text] [Related]
12. Short hairpin RNA (shRNA) constructs targeting high mobility group box-1 (HMGB1) expression leads to inhibition of prostate cancer cell survival and apoptosis. Gnanasekar M; Thirugnanam S; Ramaswamy K Int J Oncol; 2009 Feb; 34(2):425-31. PubMed ID: 19148477 [TBL] [Abstract][Full Text] [Related]
13. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. Kim JB; Lim CM; Yu YM; Lee JK J Neurosci Res; 2008 Apr; 86(5):1125-31. PubMed ID: 17975839 [TBL] [Abstract][Full Text] [Related]
14. Effects of HMGB1 on PMN apoptosis during LPS-induced acute lung injury. Feng Y; Yang Q; Xu J; Qian G; Liu Y Exp Mol Pathol; 2008 Dec; 85(3):214-22. PubMed ID: 18952078 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis. Ostberg T; Wähämaa H; Palmblad K; Ito N; Stridh P; Shoshan M; Lotze MT; Harris HE; Andersson U Arthritis Res Ther; 2008; 10(1):R1. PubMed ID: 18179697 [TBL] [Abstract][Full Text] [Related]
16. Masquerader: high mobility group box-1 and cancer. Ellerman JE; Brown CK; de Vera M; Zeh HJ; Billiar T; Rubartelli A; Lotze MT Clin Cancer Res; 2007 May; 13(10):2836-48. PubMed ID: 17504981 [TBL] [Abstract][Full Text] [Related]
17. High Mobility Group Box1 (HMGB1) released from cancer cells induces the expression of pro-inflammatory cytokines in peritoneal fibroblasts. Abe A; Kuwata T; Yamauchi C; Higuchi Y; Ochiai A Pathol Int; 2014 Jun; 64(6):267-75. PubMed ID: 24965109 [TBL] [Abstract][Full Text] [Related]
18. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. Dong Xda E; Ito N; Lotze MT; Demarco RA; Popovic P; Shand SH; Watkins S; Winikoff S; Brown CK; Bartlett DL; Zeh HJ J Immunother; 2007 Sep; 30(6):596-606. PubMed ID: 17667523 [TBL] [Abstract][Full Text] [Related]
19. Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model. Hagiwara S; Iwasaka H; Hasegawa A; Koga H; Noguchi T Crit Care Med; 2008 Aug; 36(8):2407-13. PubMed ID: 18596634 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of high mobility group box 1 (HMGB1) is associated with progression and poor prognosis in human nasopharyngeal carcinoma. Wu D; Ding Y; Wang S; Zhang Q; Liu L J Pathol; 2008 Oct; 216(2):167-75. PubMed ID: 18680137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]